Search results
From Self-sufficiency
- ...'''Zyloprim''', while in other countries it continues to be marketed by [[GlaxoSmithKline]]. Other brand names are '''Allohexal''', '''Allosig''', '''Milurit''', ''7 KB (864 words) - 16:41, 27 September 2010
- * '''Parvolex''' ([[GlaxoSmithKline|GSK]])28 KB (3,682 words) - 16:42, 27 September 2010
- ...FDA) has not approved albendazole for this indication. It is marketed by [[GlaxoSmithKline]]. Albendazole was first discovered at the SmithKline Animal Health Laborat In [[Africa]], albendazole (donated by [[GlaxoSmithKline]]) is being used to treat [[lymphatic filariasis]] as part of efforts to st10 KB (1,261 words) - 13:28, 4 September 2010
- ...en marketed worldwide under many [[trade name]]s including '''Septra''' ([[GlaxoSmithKline|GSK]]), '''Bactrim''' ([[Hoffmann-La Roche|Roche]]), and various [[generic *Septrin®, Septra® ([[GlaxoSmithKline]] and formerly [[Burroughs Wellcome]])10 KB (1,346 words) - 16:43, 27 September 2010
- ...ydrofolate reductase inhibitor]]s. Trimethoprim was formerly marketed by [[GlaxoSmithKline]] under trade names including '''Proloprim''', '''Monotrim''' and '''Tripri8 KB (1,056 words) - 20:12, 10 September 2010
- ...emier]]), ''Zovirax'', ''Aciclovir'' ([[Sanofi-Aventis]]) and ''Zovir'' ([[GlaxoSmithKline|GSK]]). One of the most commonly-used antiviral drugs, it is primarily used [[Category:GlaxoSmithKline]]14 KB (1,878 words) - 16:44, 27 September 2010
- ...[[HIV]] and [[AIDS]]. It is available under the trade name '''Ziagen''' ([[GlaxoSmithKline]]) and in the combination formulations '''Trizivir''' (abacavir, [[zidovudi8 KB (1,124 words) - 16:44, 27 September 2010
- It is marketed by GlaxoSmithKline with the brand names '''Zeffix''', '''Heptovir''', '''Epivir''', and '''Epi ...gene as first reported by Raymond Schinazi's group at Emory University. [[GlaxoSmithKline]] claimed that the M184V mutation reduces "viral fitness", because of the f9 KB (1,248 words) - 16:44, 27 September 2010
- ...997, making it the thirteenth approved antiretroviral. It is marketed by [[GlaxoSmithKline]]. *[http://www.combivir.com/ Combivir website] operated by GlaxoSmithKline3 KB (364 words) - 15:07, 6 July 2010
- ...), The Latest Advancement in the Treatment of Type 2 Diabetes |publisher=[[GlaxoSmithKline]] |date=October 12, 2002 |accessdate=2006-12-27 |url=http://www.docguide.co ...es settlement of generic Avandia, Avandamet, and Avandaryl litigation with GlaxoSmithKline |publisher=Reuters |date=September 27, 2007 |accessdate=2009-02-17}}</ref>66 KB (8,976 words) - 16:47, 27 September 2010
- ...in+clavulanate''' or simply by a trade name such as '''Augmentin''' (by [[GlaxoSmithKline]] formerly [[Beecham (pharmaceutical company)|Beecham]]),<ref name="BNF">{{ ...nted in 1984. '''Augmentin''' is the original name used by its inventor ([[GlaxoSmithKline]] formerly [[Beecham (pharmaceutical company)|Beecham]]).7 KB (895 words) - 16:48, 27 September 2010
- ...0.25 mg/mL or 0.5 mg/mL injectable solution. It is marketed by [[GlaxoSmithKline]].19 KB (2,738 words) - 16:48, 27 September 2010
- ...te is sold in the [[United Kingdom]] as '''Pentostam''' (manufactured by [[GlaxoSmithKline]]). Widespread resistance has limited the utility of sodium stibogluconate ...''', which comes in 100 ml multi-dose glass bottles manufactured by [[GlaxoSmithKline]]. It can be diluted with 5% [[dextrose]] if necessary for ease of adminis5 KB (696 words) - 15:09, 6 July 2010
- ...and as branded names ('''Azasan''' by Salix in the U.S., '''Imuran''' by [[GlaxoSmithKline]] in Canada and the U.S., Australia and UK, '''Azamun''' in Finland and ''' ...medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=3847 Imuran] (GlaxoSmithKline Patient Information Leaflet)11 KB (1,410 words) - 16:49, 27 September 2010
- Although the name may at some point have been owned by [[GlaxoSmithKline]], [[United States Patent and Trademark Office|USPTO]] registrations show "11 KB (1,555 words) - 16:49, 27 September 2010
- ...of Smith, Kline & French (prior to the merger of the two companies into [[GlaxoSmithKline]]) with the first histamine H<sub>2</sub>-receptor antagonist [[cimetidine] ....com/products/prescription-medicines/zantac.htm Zantac official website] [[GlaxoSmithKline]]5 KB (699 words) - 16:49, 27 September 2010
- ...sthma]] and [[chronic obstructive pulmonary disease]]. It is marketed by [[GlaxoSmithKline]] as '''Ventolin''', '''Aerolin''' or '''Ventorlin''' depending on the mark15 KB (2,005 words) - 16:49, 27 September 2010
- ...IDS, scientists at the [[GlaxoSmithKline|Burroughs-Wellcome Company]] (now GlaxoSmithKline) began searching for compounds to treat the disease. Burroughs-Wellcome had ...ug companies to manufacture and market generic AZT without having to pay [[GlaxoSmithKline]] any royalties. The U.S. FDA has since approved four [[generic drug|generi21 KB (3,049 words) - 16:51, 27 September 2010
- * {{cite web | author=GlaxoSmithKline |authorlink=GlaxoSmithKline |title=Amoxil - Prescribing information |year=2006 | month=February | url=h [[Category:GlaxoSmithKline]]11 KB (1,413 words) - 16:52, 27 September 2010
- ...url=http://www.medicalnewstoday.com/articles/167910.php|title=FDA Approves GlaxoSmithKline's Votrient(TM) For Advanced Renal Cell Cancer|publisher=Medical News Today|3 KB (324 words) - 13:12, 20 September 2010